InsidersTradesSigma
Follow the Simcere Pharmaceutical Group Ltd. stock price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares are listed on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Simcere Pharmaceutical Group Ltd. has logged 18 reports. Market capitalisation: €32.7bn. The latest transaction was disclosed on 24 July 2026 (Sale). Among the most active insiders: REN Jinsheng. Every trade is free.
18
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
13 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,894 of 29,063 companies
68.8
score / 100
Value54
Quality84
FCF yld4.1%
Earn yld4.7%
EV/EBITDA14.8x
ROE19%
Gross mgn82%
Net mgn17%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2026
Declarations18 total
47,000 sharesShareXHKGHKEX:DA20260724E00215
53,000 sharesShareXHKGHKEX:DA20260723E00383
100,000 sharesShareXHKGHKEX:DA20260723E00305
100,000 sharesShareXHKGHKEX:DA20260713E00576
100,000 sharesShareXHKGHKEX:DA20260709E00489
100,000 sharesShareXHKGHKEX:DA20260617E00028
100,000 sharesShareXHKGHKEX:DA20260615E00354
283,334 sharesShareXHKGHKEX:DA20260427E00010
3,000,000 sharesShareXHKGHKEX:DA20260427E00009
44,952,853 sharesShareXHKGHKEX:DA20260413E00571
18 of 18 declarations
Acerca de Simcere Pharmaceutical Group Ltd.
Simcere Pharmaceutical Group Ltd. es una empresa centrada en la investigación, el desarrollo y la comercialización de productos farmacéuticos innovadores en China. Se concentra principalmente en tratamientos para oncología y enfermedades autoinmunes.